ALIM $1.40 +.23 +20% this Gem is going back into the intraday gap at $2.55-$6.33 Nov11. Over 90% of the shares are owned by institutions! The company has 36mil cash and will get FDA approval on 2 remaining trials.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.